NDC 0310-4600 – Bevespi Aerosphere
Glycopyrrolate 9 ug/1; Formoterol Fumarate 4.8 ug/1 · Aerosol, Metered · Respiratory (inhalation)
Product NDC0310-4600
Product details
- Brand name
- Bevespi Aerosphere
- Generic name
- Glycopyrrolate and formoterol fumarate
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- Aerosol, Metered
- Route
- Respiratory (inhalation)
- Marketing category
- NDA · NDA208294
- Marketed since
- October 3, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anticholinergic; Cholinergic Muscarinic Antagonist; beta2-Adrenergic Agonist
Active ingredients
- Glycopyrrolate 9 ug/1
- Formoterol Fumarate 4.8 ug/1
Uses, dosage, side effects and warnings for Bevespi Aerosphere →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0310-4600-12 | 120 AEROSOL, METERED in 1 INHALER (0310-4600-12) | Oct 3, 2016 |
Recalls mentioning this NDC
- D-0434-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.